SRC-1 and its partner HOXC11 are highly expressed in malignant melanoma, and SRC-1 can cooperate with HOXC11 to promote the expression of S100beta, which is a stimulating factor for cell proliferation and migration and an inhibitor of cell apoptosis and differentiation [100]. Here, SRC is linked to melanoma.